v3 Template
M

Myolex, Inc.

Healthcare / Biotechnology ~135 employees
Founded
--
Employees (Est.)
~135
9 leaders known
Total Funding
$2.2M
Funding Rounds
1
Last Funding
2024-08-27

About Myolex, Inc.

Myolex is dedicated to building wellness and clinical gold standards for measuring muscle wasting and the impact of its treatment. Their goal is to assess, monitor, and display changes in skeletal muscle composition and structure to aid in the diagnosis, prognosis, and treatment of neuromuscular and musculoskeletal diseases. They are committed to supporting clinicians, scientists, caregivers, and patients battling these conditions.

Products & Services

Myolex EIM (Electrical Impedance Myography):A quantitative, painless, portable, and comprehensive device for measuring muscle composition and micro infrastructure. It serves as a potential biomarker for neuromuscular disorders, aids in earlier ALS diagnosis, acts as an alternative to MRI for muscle assessment, enables smaller clinical trials, and supports at-home use. Currently available for clinical research.

Specialties

Neuromuscular Disorders Muscle Wasting Diseases Electrical Impedance Myography (EIM) ALS Diagnosis Muscle Assessment Technology Clinical Research Tools

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 2200000
MR: -
FA: up to $2.2M
FAN: 2200000
D: 2024-08-27
FD: 2024-08-27
1 investors
Grant Latest
2024-08-27
$2.2M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Seward Rutkove

Founder and Board Director

D

Dr. Seward Rutkove

Co-founder of Myolex, Nancy Lurie Marks Chair of the Department of Neurology at Beth Israel Deaconess Medical Center, and Professor of Neurology at Harvard Medical School

N

Nan-Wei Gong

Advisory Board Member

M

Martin J Madden

Advisory Board Member

J

Jim O'Connor

Advisory Board Member

D

Dave Dickinson

CEO and Board Director

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Myolex, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
myolex.com
Industries
Healthcare / Biotechnology
Company Size
~135 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro